Microvascular mechanisms by which the combretastatin A-4 derivative AC7700 (AVE8062) induces tumour blood flow stasis

Hori, K.; Saito, S.
October 2003
British Journal of Cancer;10/6/2003, Vol. 89 Issue 7, p1334
Academic Journal
journal article
We previously reported that a novel combretastatin A-4 derivative, AC7700, has remarkable antitumour effects because of an irreversible stasis of tumour blood flow (TBF) and subsequent loss of nutrient supply to tumour tissue. Since early 2002, under the new designation AVE8062, AC7700 has undergone clinical trials in Europe and the US. Questions remain, however, concerning how AC7700 blocks TBF and why the TBF stasis does not recover. In this study, using a rat tumour LY80, a variant of Yoshida sarcoma, we examined whether TBF cessation after AC7700 administration is due to a direct action of the agent on tumour blood vessels. We constructed electrodes that can drop a small quantity of the drug solution directly at the site of blood flow measurement and inserted them subcutaneously and into the tumour. We compared the blood flow responses of normal vessels and tumour vessels after administration of 10-µl doses of various concentrations (0.2, 1, 10, and 50?mg?ml-1) of the AC7700 solution. In addition, we assessed TBF stasis after i.v. and intra-arterial 10?mg?kg-1 AC7700 administration in an LY80-induced kidney tumour. To determine why the TBF stasis is irreversible, we observed AC7700-induced changes in host arterioles and the tumour vascular network of the Sato lung carcinoma using a vital microscopic rat transparent chamber. Since an increase in tumour interstitial fluid pressure brings about a decrease in TBF, we also measured 10?mg?kg-1 AC7700-induced changes in this pressure. The sensitivity of the blood flow response after intratumoral application of AC7700 was markedly higher in normal vessels relative to tumour vessels. Intra-arterial administration of AC7700 did not have stronger effects on TBF stasis than did i.v. administration. Intravital microscopy showed that AC7700 induced a powerful and long-lasting constriction of host arterioles, so that complete stasis of blood flow occurred in downstream vessels, which supplied blood to tumours. Owing to this stasis, the lumens of numerous tumour vessels narrowed or completely disappeared, and numerous erythrocytes stagnated in drainage vessels of the tumour vascular network. Haemolysis of these erythrocytes occurred after 2-3?h, resulting in complete thrombosis. There was no indication of reperfusion in vessels showing haemolysis. This haemolysis is thought to be the main cause for the irreversibility of TBF stasis. Since the tumour interstitial fluid pressure decreased after i.v. AC7700 administration, the possibility of stasis of TBF being caused by tumour vascular compression was excluded. All these results strongly suggest that the main target of AC7700 is host arterioles and that the stasis of TBF induced by AC7700 is not triggered by a direct action of the drug on tumour vessels.British Journal of Cancer (2003) 89, 1334-1344. doi:10.1038/sj.bjc.6601261 www.bjcancer.com


Related Articles

  • Synthesis and Antitumor Evaluation of (E)-2-Benzothiazole Hydrazones. Nogueira, Ant�nio Francisco; Azevedo, Elisa Carvalho; Ferreira, Vitor Francisco; Ara�jo, Ana J�rsia; Dos Santos, Evelyne Alves; Pessoa, Claudia; Costa-Lotufo, Let�cia Veras; Montenegro, Raquel Carvalho; de Moraes, Manoel Odorico; Vasconcelos, Thatyana Rocha Alves // Letters in Drug Design & Discovery;Oct2010, Vol. 7 Issue 8, p551 

    No abstract available.

  • Exploration of hemolytic model of axial blood pump. Yanjiao Xuan; Yu Chang; Miao Song // Journal of Experimental & Integrative Medicine;2012, Vol. 2 Issue 4, p365 

    Axial flow blood pumps provide additional energy to blood for heart failure patients, but its implanting destroys the environment of blood cells; the direct consequence is hemolysis. According to energy conservation theorem, the severity of pump hemolysis depends on the energy utilization ratio...

  • A Viable Therapeutic Option: Mechanical Circulatory Support of the Failing Fontan Physiology. Throckmorton, Amy; Lopez-Isaza, Sergio; Downs, Emily; Chopski, Steven; Gangemi, James; Moskowitz, William // Pediatric Cardiology;Aug2013, Vol. 34 Issue 6, p1357 

    A blood pump specifically designed to augment flow from the great veins through the lungs would ameliorate the poor physiology of the failing univentricular circulation and result in a paradigm shift in the treatment strategy for Fontan patients. This study is the first to examine mechanical...

  • Modern blood filters do not need to be routinely changed for the majority of red blood cell transfusions in New Zealand. RUSK, D. M.; EAMES, P. M. // Anaesthesia & Intensive Care;Jul2010, Vol. 38 Issue 4, p685 

    The article discusses two experimental studies that were conducted to determine whether blood flow rate changes and/or red blood cell damage happens during red cell transfusion via a single blood filter. Measurements of flow rates of each red cell unit and saline were taken. Red blood cells were...

  • Long lasting remission by rituximab in a patient with primary cold agglutinin autoimmune haemolytic anaemia. Glaser, Marjana; Glaser, Andrej; Skalicky, Marjan // Wiener Klinische Wochenschrift;Nov2011, Vol. 123 Issue 21/22, p680 

    A 76-year-old female patient with cold agglutinin autoimmune haemolytic anaemia (CAHA) is presented. The haemolysis worsened during infection. Earlier, the patient underwent an unsuccessful treatment with steroids, chlorambucil , folic acid and heated erythrocyte transfusion. We treated her with...

  • European Society of Hematology.  // BioWorld Today;6/9/2009, Vol. 20 Issue 109, p5 

    The article reports on the observation by clinical investigators that Soliris or eculizumab reduced hemolysis and improved symptoms in nine patients with paroxysmal nocturnal hemoglobinuria (PNH) who did not received blood transfusions before initiating Soliris therapy, according to Alexion...

  • Preparation of progenin III from total steroidal saponins of Dioscorea nipponica Makino using a crude enzyme from Aspergillus oryzae strain. Liu, Tingqiang; Yu, Hongshan; Liu, Chunying; Bao, Yongming; Hu, Xiangchun; Wang, Yuanhao; Liu, Bing; Fu, Yaoyao; Tang, Sihui; Jin, Fengxie // Journal of Industrial Microbiology & Biotechnology;May2013, Vol. 40 Issue 5, p427 

    Progenin III, one of the most active spirostanol saponins, is a potential candidate for anti-cancer therapy due to its strong antitumor activity and low hemolytic activity. However, the concentration of progenin III is extremely low in natural Dioscorea plants. In this paper, the progenin III...

  • Self-Assembled Polymeric Micellar Nanoparticles as Nanocarriers for Poorly Soluble Anticancer Drug Ethaselen. Xinru Li; Zhuoli Yang; Kewei Yang; Yanxia Zhou; Xingwei Chen; Yanhui Zhang; Fei Wang; Yan Liu; Lijun Ren // Nanoscale Research Letters;Dec2009, Vol. 4 Issue 12, p1502 

    A series of monomethoxy poly(ethylene glycol)-poly(lactide) (mPEG-PLA) diblock copolymers were synthesized, and mPEG-PLA micelle was fabricated and used as a nanocarrier for solubilization and delivery of a promising anticancer drug ethaselen. Ethaselen was efficiently encapsulated into the...

  • THE EFFECT OF CYTOTOXIC DRUGS ON SERUM ALBUMIN IN THE RAT. Vincent, P. C.; Reeve, T. S.; Brittle, Nea; Nicholls, Annette; Richards, Margaret // Australian Journal of Experimental Biology & Medical Science;Aug1967, Vol. 45 Issue 4, p427 

    This article presents information regarding the effect of cytotoxic drugs on serum albumin in the rat. Although depression of gamma globulin levels is a well known effect of cytotoxic drugs, there have been no reports of a similar effects on serum albumin. During the course of a study of the...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics